GANITUMAB
UNII CK1441RCZ8

Substance Identification & Data

This profile provides standardized clinical and technical data for Ganitumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CK1441RCZ8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 905703-97-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CK1441RCZ8

CAS Registry Number

905703-97-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GANITUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C71531

National Cancer Institute reference terminology for clinical and research data.

INN ID

9323

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-139

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ganitumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GANITUMAB

Common Names & Synonyms

GANITUMAB [INN]

GANITUMAB [USAN]

GANITUMAB [WHO-DD]

IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER